Therapeutic Options to Prevent Severe COVID-19 in Immunocompromised People
Webinar/Web ConferenceOverview The U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorizations (EUA) for monoclonal antibodies to treat COVID-19 for certain patients. Monoclonal antibodies may be available through expanded access programs to treat COVID-19 for immunocompromised patients. However, the efficacy of use for immunocompromised patients is unclear. During this COCA Call, presenters will discuss... Read more »